23-valent polysaccharice pneumococcal vaccine in juvenile idiopathic arthritis patients: anti-tumor necrosis factor therapy role in short and long-term immunogenicity (2013)
- Authors:
- USP affiliated authors: BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM ; SILVA, CLOVIS ARTUR ALMEIDA DA - FM
- Unidade: FM
- Subjects: POLISSACARÍDEOS BACTERIANOS; VACINAS; NECROSE; ARTERIOSCLEROSE; RESUMOS (EVENTOS)
- Language: Inglês
- Imprenta:
- Source:
- Título: Arthristis and rheumatism
- ISSN: 0004-3591
- Volume/Número/Paginação/Ano: v. 65, n. S10, p. S923, res. 2167, 2013
- Conference titles: 2013 Annual meeting
-
ABNT
AIKAWA, Nadia E. et al. 23-valent polysaccharice pneumococcal vaccine in juvenile idiopathic arthritis patients: anti-tumor necrosis factor therapy role in short and long-term immunogenicity. Arthristis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 13 fev. 2026. , 2013 -
APA
Aikawa, N. E., França, I. L. A., Ribeiro, A. C. B., Sallum, A. M. S., Bonfá, E. S. D. de O., & Silva, C. A. A. da. (2013). 23-valent polysaccharice pneumococcal vaccine in juvenile idiopathic arthritis patients: anti-tumor necrosis factor therapy role in short and long-term immunogenicity. Arthristis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Aikawa NE, França ILA, Ribeiro ACB, Sallum AMS, Bonfá ESD de O, Silva CAA da. 23-valent polysaccharice pneumococcal vaccine in juvenile idiopathic arthritis patients: anti-tumor necrosis factor therapy role in short and long-term immunogenicity. Arthristis and rheumatism. 2013 ; 65( S10): S923.[citado 2026 fev. 13 ] -
Vancouver
Aikawa NE, França ILA, Ribeiro ACB, Sallum AMS, Bonfá ESD de O, Silva CAA da. 23-valent polysaccharice pneumococcal vaccine in juvenile idiopathic arthritis patients: anti-tumor necrosis factor therapy role in short and long-term immunogenicity. Arthristis and rheumatism. 2013 ; 65( S10): S923.[citado 2026 fev. 13 ] - Lupus nephritis-related issues during COVID-19 pandemic quarantine
- Initial Benchmarking of the Quality of Medical Care in Childhood-Onset Systemic Lupus Erythematosus
- High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting
- Latent tuberculosis infection screening in juvenile idiopathic arthritis patients preceding anti-TNF therapy in a tuberculosis high-risk country
- Therapeutic guidelines for Latin American Lupus patients methodology
- Long-term evaluation of cardiac function in juvenile idiopathic arthritis under anti-tumor necrosis factor therapy
- Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis
- Ozone decreases sperm quality in systemic lupus erythematosus patients
- Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy
- Human Papilloma Virus and Chlamydia Trachomatis Infections in Rheumatoid Arthitis Under Anti-TNF Therapy
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
